AU2003273969A1 - Sulfonamide derivatives as antipsychotic agents - Google Patents

Sulfonamide derivatives as antipsychotic agents

Info

Publication number
AU2003273969A1
AU2003273969A1 AU2003273969A AU2003273969A AU2003273969A1 AU 2003273969 A1 AU2003273969 A1 AU 2003273969A1 AU 2003273969 A AU2003273969 A AU 2003273969A AU 2003273969 A AU2003273969 A AU 2003273969A AU 2003273969 A1 AU2003273969 A1 AU 2003273969A1
Authority
AU
Australia
Prior art keywords
sub
sup
alkyl
cycloalkyl
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003273969A
Other languages
English (en)
Inventor
Ian Thomson Forbes
Andrew Derrick Gribble
Andrew P. Lightfoot
Andrew H. Payne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0223226A external-priority patent/GB0223226D0/en
Priority claimed from GB0223236A external-priority patent/GB0223236D0/en
Priority claimed from GB0314627A external-priority patent/GB0314627D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2003273969A1 publication Critical patent/AU2003273969A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Indole Compounds (AREA)
AU2003273969A 2002-10-07 2003-10-06 Sulfonamide derivatives as antipsychotic agents Abandoned AU2003273969A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0223226A GB0223226D0 (en) 2002-10-07 2002-10-07 Compounds
GB0223236.1 2002-10-07
GB0223226.2 2002-10-07
GB0223236A GB0223236D0 (en) 2002-10-07 2002-10-07 Compouds
GB0314627.1 2003-06-23
GB0314627A GB0314627D0 (en) 2003-06-23 2003-06-23 Novel compounds
PCT/EP2003/011174 WO2004031181A1 (en) 2002-10-07 2003-10-06 Sulfonamide derivatives as antipsychotic agents

Publications (1)

Publication Number Publication Date
AU2003273969A1 true AU2003273969A1 (en) 2004-04-23

Family

ID=32073912

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003273969A Abandoned AU2003273969A1 (en) 2002-10-07 2003-10-06 Sulfonamide derivatives as antipsychotic agents

Country Status (8)

Country Link
US (1) US7122538B2 (cg-RX-API-DMAC7.html)
EP (1) EP1549639B1 (cg-RX-API-DMAC7.html)
JP (1) JP2006504794A (cg-RX-API-DMAC7.html)
AT (1) ATE327234T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003273969A1 (cg-RX-API-DMAC7.html)
DE (1) DE60305519T2 (cg-RX-API-DMAC7.html)
ES (1) ES2264003T3 (cg-RX-API-DMAC7.html)
WO (1) WO2004031181A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050137186A1 (en) * 2003-12-18 2005-06-23 Abbott Gmbh & Co. Kg. Tetrahydrobenzazepines and their use
US8207160B2 (en) 2003-12-18 2012-06-26 Abbott Gmbh & Co. Kg Tetrahydrobenzazepines and their use in he modulation of the dopamine D3 receptor
ATE487715T1 (de) * 2005-08-22 2010-11-15 Glaxo Group Ltd Triazolderivate als modulatoren von dopamin-d3- rezeptoren
EP1837332A1 (en) * 2006-03-23 2007-09-26 Laboratorios Del Dr. Esteve, S.A. Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
US7897595B2 (en) 2006-05-26 2011-03-01 Forest Laboratories Holdings Limited Pyridoazepine derivatives
WO2007149728A2 (en) * 2006-06-20 2007-12-27 Alcon Research, Ltd. Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma
CN110430875A (zh) 2017-01-13 2019-11-08 大日本住友制药株式会社 用于与帕金森病相关的非运动症状的治疗剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA792785B (en) 1978-07-07 1980-08-27 Smithkline Corp Mercapto substituted-2,3,4,5-tetrahydro-1h-3-benzazepines
GB9926302D0 (en) 1999-11-05 2000-01-12 Smithkline Beecham Plc Novel compounds
CA2394603A1 (en) 1999-12-21 2001-06-28 Dashyant Dhanak Urotensin-ii receptor antagonists
DE10053799A1 (de) 2000-10-30 2002-05-08 Bayer Ag Verwendung von Tetrahydroisochinolinsulfonamiden
PL371344A1 (en) 2002-02-13 2005-06-13 Glaxo Group Limited Benzenesulfonamide derivatives as antipsychotic agents

Also Published As

Publication number Publication date
DE60305519T2 (de) 2006-11-23
ATE327234T1 (de) 2006-06-15
JP2006504794A (ja) 2006-02-09
EP1549639A1 (en) 2005-07-06
US7122538B2 (en) 2006-10-17
EP1549639B1 (en) 2006-05-24
ES2264003T3 (es) 2006-12-16
WO2004031181A1 (en) 2004-04-15
US20060063757A1 (en) 2006-03-23
DE60305519D1 (de) 2006-06-29

Similar Documents

Publication Publication Date Title
AU2001235844A1 (en) Imidazol-2-carboxamide derivatives as raf kinase inhibitors
WO2004112710A3 (en) COMPOSITIONS AND METHODS FOR INHIBITING TGF-ß
WO2006067614A3 (en) Heteroaromatic derivatives useful as anticancer agents
MY139446A (en) Novel quinoline derivatives
NO20082101L (no) Pyrido-, pyrazo- og pyrimido-pyrimidinderivater som mTor inhibitorer
BR0315405A (pt) Compostos inibidores da integrase tricìclica pré-organizados
DE60027648D1 (de) Sulfonamide enthaltende indolderivate
GB0114286D0 (en) Nucleoside Derivatives
WO2006049835A3 (en) Indole and benzimidazole derivatives
CA2510853A1 (en) Pyrrolopyrimidine derivatives
ZA200708159B (en) 1-Acetic acid-indole derivatives with PDG2 antagonist activity
WO2003082205A3 (en) Compounds and methods
DE602006011752D1 (de) Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
DK1643984T3 (da) Anvendelse af parthenolidderivater som antileukæmiske og cytotoksske midler
PL373397A1 (en) Arylsulfonyl derivatives with 5-ht6 receptor affinity
PL353646A1 (en) Aminobenzophenones as inhibitors of il-1beta and tnf-alpha
MY138826A (en) 2,7-substituted indoles
ATE429429T1 (de) Pharmazeutisches verfahren und damit hergestellte verbindungen
DE60206505D1 (de) Substituierte benzopyran derivate gegen arrhythmie
ATE327234T1 (de) Sulfonamidderivate als antipsychotische mittel
WO2004067703A3 (en) 5ht7 antagonists and inverse agonists
WO2007017728A3 (en) Novel heterocyclic compounds
WO2009019721A3 (en) Quercetin derivatives as anti-cancer agents
IL188927A0 (en) Aryloxy quinolines and uses thereof as 5-ht6 modulators

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase